It has been hypothesized that the pleotropic substrate repertoire of SMURF2, including its interactors and targets which have not yet been identified, and the differential access of SMURF2 to its interactors in normal and cancer cells are related to its duality. This evidence concerns the gene SMURF2 and cancer.